CAPR Forecast + Trading Strategies




Price Forecast:


Bearish<->Bullish




Bullish Case: If CAP-1002 gains FDA approval, we can expect a significant price surge, fueled by unmet needs in DMD treatment and recent positive trial results. Historical returns support high price gains over time.




Bearish Case: If FDA approval is delayed or failed, we could see a substantial price drop, exacerbated by higher implied volatility in puts and negative market sentiment influencing CAPR sharply downward.




Potential Outcomes:

1. FDA approval of CAP-1002 (40%) – price surge projected.

2. Delay in clinical trial results (25%) – increased volatility expected.

3. Strategic buyout (20%) – minor price increase.

4. Clinical trial failure (15%) – severe price drop predicted.




Trading Oracle: Consider a bullish long debit spread using CAPR 12/20/2024 $20 calls and selling $25 calls. High implied volatility indicates favorable risk-reward, targeting FDA approval catalysts within 47 days. Historical performance suggests a good probability of profit, trimming downside risk while maximizing upside potential.



November 03, 2024


Capricor Therapeutics Forecast

CAPR        Capricor Therapeutics











Correlated Assets

Assets that tend to move strongly with CAPR



RJF Forecast + Options Trading Strategies   RJF  Raymond James Financial (0.85)


DAL Forecast + Options Trading Strategies   DAL  Delta Air Lines (0.83)


OPRA Forecast + Options Trading Strategies   OPRA  Opera (0.82)


CAT Forecast + Options Trading Strategies   CAT  Caterpillar (0.79)


VRT Forecast + Options Trading Strategies   VRT  Vertiv (0.77)



Uncorrelated Assets

Assets with little price relationship to CAPR



FSK Forecast + Options Trading Strategies   FSK  FS KKR (0.0)


MEOH Forecast + Options Trading Strategies   MEOH  Methanex (0.0)


VCLT Forecast + Options Trading Strategies   VCLT  Vanguard Long-Term Corporate Bond (-0.0)


THO Forecast + Options Trading Strategies   THO  Thor Industries (0.0)


MRNA Forecast + Options Trading Strategies   MRNA  Moderna (0.0)



Anticorrelated Assets

Assets that tend to move strongly against CAPR



HE Forecast + Options Trading Strategies   HE  Hawaiian Electric Industries (-0.65)


ERY Forecast + Options Trading Strategies   ERY  Direxion Daily Energy Bear 2X Shares (-0.65)


FLGT Forecast + Options Trading Strategies   FLGT  Fulgent Genetics (-0.66)


HUM Forecast + Options Trading Strategies   HUM  Humana (-0.75)


CNXC Forecast + Options Trading Strategies   CNXC  Concentrix (-0.77)









Become a more profitable investor with AI optimized trading strategies






×

Chat with CAPR


 Ask any question about CAPR!